Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Ebitda Per Share

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY.

The item "Ebitda-Per-Share" stands at 726.62 Japanese Yens as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Ebitda Per Share" stands at 726.62 JPY. This represents a decrease of -5.85 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -8.23 percent compared to the value the year prior.
The 1 year change in percent is -8.23.
The 3 year change in percent is 8.79.

The Serie's long term average value is 730.91 Japanese Yens. It's latest available value, on 09/30/2025, is 0.587 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +12.48%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -11.07%.

Ebitda Per Share for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda Per Share905,699,262,464.00
LogoJohnson & Johnson - Ebitda Per Share486,508,953,600.00
LogoAbbVie Inc - Ebitda Per Share399,570,305,024.00
LogoRoche Holding AG - Ebitda Per Share317,433,206,677.55
LogoAstraZeneca PLC - Ebitda Per Share280,205,508,085.11